Eline L Giraud

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Metastatic Renal Cell Carcinoma

Quality Control

End Stage Renal Disease

Prognostic Factors

Top Venues

British journal of clinical pharmacology

Expert opinion on drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Eline L Giraud, Stefanie D Krens, Stefan Böhringer, Ingrid M E Desar, Sita H Vermeulen, Lambertus A Kiemeney, Alwin D R Huitema, Neeltje Steeghs, Nielka P van Erp, Jesse Joachim Swen
Exploring the contribution of genetic variants to high sunitinib exposure in patients with cancer. British journal of clinical pharmacology (2024)
Eline L Giraud, Lindsey M H Te Brake, Erik C A van den Hombergh, Ingrid M E Desar, Dina M Kweekel, Nielka P van Erp
Results of the first international quality control programme for oral targeted oncolytics. British journal of clinical pharmacology (2023)
Eline L Giraud, Loek A W de Jong, Erik van den Hombergh, Suzanne E J Kaal, Nielka P van Erp, Ingrid M E Desar
Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant? Cancers 15 (11) (2023)
Eline L Giraud, Naomi T Jessurun, Florence P A M van Hunsel, Eugene P van Puijenbroek, Astrid van Tubergen, Peter M Ten Klooster, Harald E Vonkeman
Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patients. Expert opinion on drug safety 19 (12) (2020)